Recent Quarter Total Invested
$3.28 M
Recent Quarter Institutional Ownership Percentage
3.82%
Total Invested of Last Quarter
$3.86 M
Ownership Percentage of Last Quarter
3.89%
Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 634,047 | $1.50 M | 0.00% | 1.75% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 107,066 | $253,812 | 0.54% | 0.30% |
EDGEWOOD MANAGEMENT LLC | 11/12/2024 | 100,000 | $237,000 | 0.00% | 0.28% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 75,382 | $178,655 | -16.60% | 0.21% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 46,496 | $110,196 | -3.53% | 0.13% |
STATE STREET CORP | 11/14/2024 | 40,300 | $95,511 | 0.00% | 0.11% |
SEACREST WEALTH MANAGEMENT, LLC | 10/16/2024 | 34,954 | $82,841 | 0.00% | 0.10% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 29,786 | $70,593 | -53.47% | 0.08% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 23,803 | $56,413 | 100.00% | 0.07% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 20,314 | $48,144 | 100.00% | 0.06% |
CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 13,140 | $31,142 | 0.00% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 10,300 | $24,411 | -79.28% | 0.03% |
CITADEL ADVISORS LLC | 11/14/2024 | 7,800 | $18,486 | -52.67% | 0.02% |
CITADEL ADVISORS LLC | 11/14/2024 | 7,000 | $16,590 | 0.00% | 0.02% |
UBS GROUP AG | 11/14/2024 | 2,357 | $5,586 | 235,600.00% | 0.01% |
TRIFECTA CAPITAL ADVISORS, LLC | 10/16/2024 | 714 | $1,693 | 0.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 571 | $1,353 | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 11/14/2024 | 400 | $948 | 300.00% | 0.00% |
MORGAN STANLEY | 11/14/2024 | 109 | $258 | 5,350.00% | 0.00% |
SALEM INVESTMENT COUNSELORS INC | 10/15/2024 | 100 | $237 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 11/08/2024 | 26 | $62 | -3.70% | 0.00% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 1 | $1 | 0.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Armata Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ARMP shares?
During the previous two years, 22 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BANK OF AMERICA CORP /DE/: 634,047
GEODE CAPITAL MANAGEMENT, LLC: 107,066
EDGEWOOD MANAGEMENT LLC: 100,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 75,382
RENAISSANCE TECHNOLOGIES LLC: 46,496
STATE STREET CORP: 40,300
-
What percentage of Armata Pharmaceuticals, Inc. stock is owned by institutional investors?
3.82% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ARMP ?
Institutional investors have bought a total of 1.16 M shares in the last 24 months. This purchase volume represents approximately $2.62 M in transactions.